Best Medical Stocks To Own For 2019

tags:ABT,CSL,BAESY,IPHS,ASTE,

President & CEO of Nektar Therapeutics Inc (NASDAQ:NKTR) Howard W Robin sold 83,333 shares of NKTR on 01/22/2018 at an average price of $75.82 a share. The total sale was $6.3 million.

Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides. Nektar Therapeutics Inc has a market cap of $12.05 billion; its shares were traded at around $76.53 with and P/S ratio of 48.58.

CEO Recent Trades:

President & CEO Howard W Robin sold 83,333 shares of NKTR stock on 01/22/2018 at the average price of $75.82. The price of the stock has increased by 0.94% since.

Directors and Officers Recent Trades:

Director Christopher A Kuebler sold 30,000 shares of NKTR stock on 01/02/2018 at the average price of $58.66. The price of the stock has increased by 30.46% since.

For the complete insider trading history of NKTR, click here

Best Medical Stocks To Own For 2019: Abbott Laboratories(ABT)

Advisors' Opinion:

• [By Todd Campbell]

  Until competitor Abbott Labs (NYSE:ABT) won approval of its Freestyle Libre CGM last year, patients still had to use fingersticks to calibrate their CGMs. The approval of the Freestyle Libre did away with that requirement, significantly reducing patient burden and, in the process, giving Abbott Labs an edge in the CGM market.

• [By Logan Wallace]

  Charter Trust Co. lowered its position in Abbott Laboratories (NYSE:ABT) by 1.4% in the 2nd quarter, HoldingsChannel reports. The fund owned 164,048 shares of the healthcare product maker’s stock after selling 2,350 shares during the quarter. Abbott Laboratories accounts for 1.2% of Charter Trust Co.’s holdings, making the stock its 23rd biggest holding. Charter Trust Co.’s holdings in Abbott Laboratories were worth $10,005,000 as of its most recent SEC filing.

• [By ]

  Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Best Medical Stocks To Own For 2019: Carlisle Companies Incorporated(CSL)

Advisors' Opinion:

• [By Lisa Levin] Gainers Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform. Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million. AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61. Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results. Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71. China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64. Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass. Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results. Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results. Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday. USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results. SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million. K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results. Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings. Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter. Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
• [By Logan Wallace]

  Carlisle Companies, Inc. (NYSE:CSL) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 1,387,833 shares, a decrease of 42.1% from the July 31st total of 2,398,744 shares. Approximately 2.4% of the company’s stock are sold short. Based on an average trading volume of 396,065 shares, the days-to-cover ratio is currently 3.5 days.

• [By Ethan Ryder]

  West Pharmaceutical Services (NYSE: WST) and Carlisle Companies (NYSE:CSL) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

• [By Joseph Griffin]

  SG Americas Securities LLC trimmed its position in Carlisle Companies (NYSE:CSL) by 5.9% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,215 shares of the conglomerate’s stock after selling 706 shares during the quarter. SG Americas Securities LLC’s holdings in Carlisle Companies were worth $1,171,000 at the end of the most recent reporting period.

• [By Lisa Levin] Gainers Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform. Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results. Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60. K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results. Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer. Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter. Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings. Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating. Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday. Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results. STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

  Check out these big penny stock gainers and losers

• [By Shane Hupp]

  Press coverage about Carlisle Companies (NYSE:CSL) has trended somewhat positive on Saturday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Carlisle Companies earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave news coverage about the conglomerate an impact score of 45.7996936905604 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Best Medical Stocks To Own For 2019: BAE Systems PLC (BAESY)

Advisors' Opinion:

• [By Rich Smith]

  Britain's BAE Systems (NASDAQOTH:BAESF) (NASDAQOTH:BAESY) is a behemoth, doing more than $24 billion in annual business and valued in excess of $26 billion -- yet it's largely unknown to U.S. investors, a consequence of its stock being traded over the counter and not on major U.S. stock exchanges like the NYSE or Nasdaq. That could change, however, with BAE winning a big endorsement from investment megabank Morgan Stanley this morning.

• [By Lou Whiteman]

  The Marine Corps has selected BAE Systems (NASDAQOTH:BAESY) to manufacture its next-generation amphibious combat vehicle, dealing a major setback to the diversification plans of Science Applications International (NYSE:SAIC).

• [By Logan Wallace]

  BEACH ENERGY Lt/ADR (OTCMKTS:BCHEY) and BAE SYS PLC/S (OTCMKTS:BAESY) are both oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

• [By Jason Hall, Rich Smith, and Travis Hoium]

  But that doesn't mean investors looking to add defense stocks to their portfolio should avoid the entire sector; there are opportunities to be had. These Motley Fool contributors have identified two companies with substantial military and commercial opportunities in AeroVironment, Inc. (NASDAQ:AVAV) and Boeing Co. (NYSE:BA), as well as undervalued British defense giant BAE Systems PLC (ADR) (NASDAQOTH:BAESY) as defense stocks worth watching closely this month. 

Best Medical Stocks To Own For 2019: Innophos Holdings, Inc.(IPHS)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Innophos (IPHS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  TheStreet upgraded shares of Innophos (NASDAQ:IPHS) from a c+ rating to a b rating in a research note published on Wednesday.

  Several other analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Innophos from a hold rating to a sell rating in a report on Tuesday, February 27th. BidaskClub downgraded shares of Innophos from a sell rating to a strong sell rating in a report on Tuesday, February 27th.

• [By Motley Fool Transcribers]

  Innophos Holdings Inc  (NASDAQ:IPHS)Q4 2018 Earnings Conference CallFeb. 20, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Innophos (IPHS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  BidaskClub upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Best Medical Stocks To Own For 2019: Astec Industries, Inc.(ASTE)

Advisors' Opinion:

• [By Max Byerly]

  TRADEMARK VIOLATION WARNING: “Teton Advisors Inc. Increases Holdings in Astec Industries, Inc. (ASTE)” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/4118848/teton-advisors-inc-increases-holdings-in-astec-industries-inc-aste.html.

• [By Logan Wallace]

  Dean Investment Associates LLC boosted its holdings in Astec Industries, Inc. (NASDAQ:ASTE) by 5.1% in the first quarter, HoldingsChannel.com reports. The firm owned 59,000 shares of the industrial products company’s stock after acquiring an additional 2,870 shares during the period. Dean Investment Associates LLC’s holdings in Astec Industries were worth $3,256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By Shane Hupp]

  UBS Group AG cut its stake in Astec Industries, Inc. (NASDAQ:ASTE) by 13.2% in the 1st quarter, HoldingsChannel reports. The firm owned 34,122 shares of the industrial products company’s stock after selling 5,211 shares during the quarter. UBS Group AG’s holdings in Astec Industries were worth $1,883,000 as of its most recent filing with the SEC.

• [By Stephan Byrd]

  Shares of Astec Industries (NASDAQ:ASTE) have received an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $67.25.

• [By Logan Wallace]

  Douglas Dynamics (NYSE: PLOW) and Astec Industries (NASDAQ:ASTE) are both small-cap auto/tires/trucks companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.